“Partnering with Genesis Therapeutics presents a unique opportunity to leverage their AI technologies to accelerate the discovery of breakthrough small molecules for high-impact targets in our ...

The company’s fifty day moving average price ... of Genesis Energy by 2.9% during the 3rd quarter. Captrust Financial Advisors now owns 31,720 shares of the pipeline company’s stock valued ...

The collaboration will leverage Genesis' GEMS or Genesis Exploration of Molecular Space artificial intelligence or AI platform to discover and optimize novel therapeutics for Incyte-selected targets.

We recently published a list of 12 AI Updates Worth Taking a Look At. In this article, we are going to take a look at where Incyte Corporation (NASDAQ:INCY) stands against other AI updates worth ...

In this article, we are going to take a look at where Genesis ... AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an ...